美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Niagen Bioscience

4.53

+0.00500.11%

成交量：4.76萬

成交額：21.26萬

市值：3.62億

市盈率：22.63

高：4.53

開：4.45

低：4.40

收：4.52

52周最高：14.69

52周最低：4.39

股本：7,992.00萬

流通股本：5,141.47萬

量比：0.56

換手率：0.09%

股息：- -

股息率：- -

每股收益(TTM):0.2000

每股收益(LYR):0.2000

淨資產收益率：28.35%

總資產收益率：10.23%

市淨率：4.73

市盈率(LYR):22.63

資料載入中...

總覽公司新聞資訊公告

Niagen Bioscience與全球頂尖機構就Niagen®達成逾300項外部研究協議，助力45項臨床研究發表

Niagen Bioscience 2025財年淨銷售額按年增長30%至1.294億美元，淨利潤激增103%至1740萬美元，基本每股收益0.22美元

Niagen Bioscience通過全現金交易向LGC出售Chromadex參考標準業務，精簡運營聚焦主業

BUZZ-Niagen Bioscience 股價因注射用 NAD+ 增效劑的美國專利而上漲

Niagen Bioscience公司獲得煙酰胺核苷靜脈注射與注射製劑及使用方法的新美國專利

Niagen Bioscience收購自貝爾法斯特女王大學的核心煙酰胺核糖（Nr）專利組合

Niagen Bioscience宣佈1000萬美元股票回購計劃

Niagen Bioscience Inc：全年重申其最近修訂的淨銷售額增長指引為按年增長25%至30%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NAGE/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NAGE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAGE\",,,,,undefined,":{"symbol":"NAGE","market":"US","secType":"STK","nameCN":"Niagen Bioscience","latestPrice":4.525,"timestamp":1774533762543,"preClose":4.52,"halted":0,"volume":47561,"delay":0,"changeRate":0.0011061946902656597,"floatShares":51414700,"shares":79919957,"eps":0.2,"marketStatus":"交易中","change":0.005,"latestTime":"03-26 10:02:43 EDT","open":4.45,"high":4.53,"low":4.4,"amount":212577.9512094,"amplitude":0.028761,"askPrice":4.53,"askSize":117,"bidPrice":4.52,"bidSize":193,"shortable":3,"etf":0,"ttmEps":0.2,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1774555200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":4.52,"preHourTrading":{"tag":"盘前","latestPrice":4.45,"preClose":4.52,"latestTime":"09:25 EDT","volume":1806,"amount":8110.997034000001,"timestamp":1774531501424,"change":-0.07,"changeRate":-0.015487,"amplitude":0.015487},"postHourTrading":{"tag":"盘后","latestPrice":4.5,"preClose":4.52,"latestTime":"18:36 EDT","volume":27202,"amount":122968.945,"timestamp":1774478186161,"change":-0.02,"changeRate":-0.004425,"amplitude":0.013274},"volumeRatio":0.561006,"impliedVol":1.564,"impliedVolPercentile":0.8805},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAGE\",,,,,undefined,":{"symbol":"NAGE","floatShares":51414700,"roa":"10.23%","roe":"28.35%","lyrEps":0.2,"volumeRatio":0.561006,"shares":79919957,"dividePrice":0,"high":4.53,"amplitude":0.028761,"preClose":4.52,"low":4.4,"week52Low":4.39,"pbRate":"4.73","psRate":"2.79","week52High":14.69,"institutionHeld":0,"latestPrice":4.525,"committee":0.245161,"eps":0.2,"divideRate":0,"volume":47561,"delay":0,"ttmEps":0.2,"open":4.45,"prevYearClose":6.36,"prevWeekClose":4.66,"prevMonthClose":5.05,"prevQuarterClose":6.36,"fiveDayClose":4.74,"twentyDayClose":5.18,"sixtyDayClose":6.59},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NAGE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-04","symbol":"NAGE","fiscalQuarterEnding":"2025/12","expectedEps":0.02,"name":null,"time":"盤後","type":"earning","dateTimestamp":1772600400000,"reportTimeType":"post","actualEps":0.03},{"market":"US","date":"2025-11-04","symbol":"NAGE","fiscalQuarterEnding":"2025/09","expectedEps":0.02,"name":null,"time":"盤後","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":0.05},{"market":"US","date":"2025-08-06","symbol":"NAGE","fiscalQuarterEnding":"2025/06","expectedEps":0.02,"name":null,"time":"盤後","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":0.04},{"market":"US","date":"2025-05-07","symbol":"NAGE","fiscalQuarterEnding":"2025/03","expectedEps":0.02,"name":null,"time":"盤後","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":0.04},{"market":"US","date":"2025-03-04","symbol":"NAGE","fiscalQuarterEnding":"2024/12","expectedEps":0.02,"name":null,"time":"盤後","type":"earning","dateTimestamp":1741064400000,"reportTimeType":"post","actualEps":0.03}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NAGE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NAGE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1748404800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NAGE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NAGE","date":"2026-03-25","current":22.625,"percent":0.070866,"low":19.052974,"twenty":24.917841,"median":42.779649,"eighty":62.643805,"high":80.643552,"avg":43.070506,"sd":18.608908,"marketCap":364323595},"quantilePoints":[{"date":"2025-03-21","current":69.624479,"twenty":69.806742,"median":70.080136,"eighty":70.353531,"marketCap":595289295},{"date":"2025-03-28","current":67.346191,"twenty":68.676711,"median":69.624479,"eighty":70.371757,"marketCap":575809933},{"date":"2025-04-04","current":60.420196,"twenty":62.662031,"median":67.938546,"eighty":69.697384,"marketCap":516592673},{"date":"2025-04-11","current":51.67157,"twenty":54.861173,"median":62.880747,"eighty":69.551574,"marketCap":441791924},{"date":"2025-04-17","current":59.600012,"twenty":54.815607,"median":61.696037,"eighty":69.259953,"marketCap":509580103},{"date":"2025-04-25","current":67.255059,"twenty":55.043436,"median":62.151694,"eighty":68.530901,"marketCap":575030758},{"date":"2025-05-02","current":68.895427,"twenty":55.954751,"median":62.880747,"eighty":69.442216,"marketCap":589055899},{"date":"2025-05-09","current":51.710369,"twenty":55.954751,"median":65.022337,"eighty":70.535794,"marketCap":729374756},{"date":"2025-05-16","current":58.761783,"twenty":54.815607,"median":62.789615,"eighty":69.71561,"marketCap":828834951},{"date":"2025-05-23","current":56.859021,"twenty":55.043436,"median":61.650471,"eighty":69.624479,"marketCap":801996485},{"date":"2025-05-30","current":60.552618,"twenty":55.242319,"median":61.364091,"eighty":69.478669,"marketCap":854094682},{"date":"2025-06-06","current":64.414107,"twenty":55.822209,"median":61.604905,"eighty":69.296406,"marketCap":908560979},{"date":"2025-06-13","current":79.132535,"twenty":56.409541,"median":62.698483,"eighty":70.55402,"marketCap":1116164400},{"date":"2025-06-20","current":77.117845,"twenty":56.623974,"median":63.647427,"eighty":71.912091,"marketCap":1087747202},{"date":"2025-06-27","current":77.341699,"twenty":56.791865,"median":65.523561,"eighty":75.181504,"marketCap":1090904668},{"date":"2025-07-03","current":71.129739,"twenty":57.426855,"median":65.645306,"eighty":75.483707,"marketCap":1003284974},{"date":"2025-07-11","current":65.981088,"twenty":58.471876,"median":66.48476,"eighty":75.192697,"marketCap":930663244},{"date":"2025-07-18","current":57.950311,"twenty":58.471876,"median":65.645306,"eighty":75.114348,"marketCap":817389135},{"date":"2025-07-25","current":51.87826,"twenty":56.758286,"median":65.022337,"eighty":74.190401,"marketCap":731742856},{"date":"2025-08-01","current":52.325969,"twenty":55.224884,"median":64.358143,"eighty":72.732275,"marketCap":738057789},{"date":"2025-08-08","current":43.320593,"twenty":54.318273,"median":62.947882,"eighty":72.15947,"marketCap":768030786},{"date":"2025-08-15","current":43.771379,"twenty":53.985743,"median":62.607352,"eighty":71.628921,"marketCap":776022782},{"date":"2025-08-22","current":44.041851,"twenty":52.415511,"median":61.650471,"eighty":71.37484,"marketCap":780817979},{"date":"2025-08-29","current":44.267244,"twenty":51.68709,"median":61.280145,"eighty":71.129739,"marketCap":784813977},{"date":"2025-09-05","current":42.013311,"twenty":50.71606,"median":60.552618,"eighty":71.083855,"marketCap":744853999},{"date":"2025-09-12","current":43.365671,"twenty":45.745824,"median":60.318517,"eighty":70.845641,"marketCap":768829986},{"date":"2025-09-19","current":45.709762,"twenty":45.222912,"median":59.50888,"eighty":70.6087,"marketCap":810388363},{"date":"2025-09-26","current":42.419019,"twenty":45.024566,"median":58.520194,"eighty":70.371757,"marketCap":752046795},{"date":"2025-10-03","current":33.268051,"twenty":44.46559,"median":56.887002,"eighty":69.697384,"marketCap":589809282},{"date":"2025-10-10","current":34.079467,"twenty":44.02382,"median":56.607185,"eighty":69.623328,"marketCap":604194874},{"date":"2025-10-17","current":33.448366,"twenty":43.66319,"median":55.29204,"eighty":69.583421,"marketCap":593006080},{"date":"2025-10-24","current":33.448366,"twenty":43.41075,"median":54.929521,"eighty":69.405763,"marketCap":593006080},{"date":"2025-10-31","current":32.050928,"twenty":43.28453,"median":54.228731,"eighty":69.187048,"marketCap":568230894},{"date":"2025-11-07","current":25.87441,"twenty":42.455082,"median":54.050915,"eighty":68.822522,"marketCap":528588317},{"date":"2025-11-14","current":27.403352,"twenty":42.022327,"median":53.333314,"eighty":68.390298,"marketCap":559823081},{"date":"2025-11-21","current":26.30565,"twenty":34.151593,"median":52.437896,"eighty":67.731548,"marketCap":537398122},{"date":"2025-11-28","current":26.540872,"twenty":33.854074,"median":52.018169,"eighty":67.346191,"marketCap":542203471},{"date":"2025-12-05","current":26.266446,"twenty":33.628681,"median":51.67157,"eighty":67.255059,"marketCap":536597231},{"date":"2025-12-12","current":25.992021,"twenty":33.448366,"median":50.903505,"eighty":67.255059,"marketCap":530990991},{"date":"2025-12-19","current":25.482373,"twenty":32.772186,"median":49.393282,"eighty":66.988433,"marketCap":520579403},{"date":"2025-12-26","current":25.913613,"twenty":32.474667,"median":46.160548,"eighty":66.182557,"marketCap":529389208},{"date":"2026-01-02","current":24.933522,"twenty":30.002996,"median":45.709762,"eighty":65.94751,"marketCap":509366924},{"date":"2026-01-09","current":25.717595,"twenty":27.520963,"median":45.43929,"eighty":65.757233,"marketCap":525384751},{"date":"2026-01-16","current":24.737504,"twenty":27.019156,"median":45.168818,"eighty":65.594939,"marketCap":505362467},{"date":"2026-01-23","current":24.619893,"twenty":26.909386,"median":44.627874,"eighty":65.546241,"marketCap":502959792},{"date":"2026-01-30","current":23.482987,"twenty":26.540872,"median":44.492638,"eighty":65.122582,"marketCap":479733942},{"date":"2026-02-06","current":20.111473,"twenty":26.282128,"median":44.267244,"eighty":64.478311,"marketCap":410857283},{"date":"2026-02-13","current":19.954658,"twenty":25.944976,"median":44.008043,"eighty":64.391721,"marketCap":407653717},{"date":"2026-02-20","current":19.366604,"twenty":25.843047,"median":43.816458,"eighty":64.134289,"marketCap":395640346},{"date":"2026-02-27","current":20.307491,"twenty":25.623506,"median":43.591065,"eighty":63.1941,"marketCap":414861740},{"date":"2026-03-06","current":23.545172,"twenty":25.529418,"median":43.41075,"eighty":62.988163,"marketCap":409262188},{"date":"2026-03-13","current":22.252496,"twenty":25.411807,"median":43.320593,"eighty":62.862521,"marketCap":386792892},{"date":"2026-03-20","current":21.88316,"twenty":25.058974,"median":43.095199,"eighty":62.753162,"marketCap":380373093},{"date":"2026-03-25","current":20.95982,"twenty":24.917841,"median":42.779649,"eighty":62.643805,"marketCap":364323595}],"updateTime":1774533763954},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NAGE\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1171944922","title":"Niagen Bioscience與全球頂尖機構就Niagen®達成逾300項外部研究協議，助力45項臨床研究發表","url":"https://stock-news.laohu8.com/highlight/detail?id=1171944922","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171944922?lang=zh_tw&edition=fundamental","pubTime":"2026-03-17 20:32","pubTimestamp":1773750774,"startTime":"0","endTime":"0","summary":"Niagen Bioscience近日宣布，其与全球多家顶尖科研机构就核心成分Niagen®签署的外部研究协议已突破300项。这一重要进展进一步推动了相关临床研究的发展，目前已有45项基于Niagen®的临床研究在权威期刊上正式发表。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE","BK4183","BK4121"],"gpt_icon":0},{"id":"1142110680","title":"Niagen Bioscience 2025財年淨銷售額按年增長30%至1.294億美元，淨利潤激增103%至1740萬美元，基本每股收益0.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1142110680","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142110680?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 05:03","pubTimestamp":1772658211,"startTime":"0","endTime":"0","summary":"Niagen Bioscience（股票代码：NAGE）近日公布了其2025财年财务业绩，表现亮眼。公司净销售额达到1.294亿美元，较去年同期大幅增长30%。盈利能力方面更是实现飞跃，净利润录得1740万美元，同比飙升103%。按基本每股收益计算，该公司2025财年实现每股收益0.22美元。\n这一强劲的增长势头主要得益于核心产品在市场中的需求持续旺盛以及公司运营效率的显著提升。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","NAGE","BK4121"],"gpt_icon":0},{"id":"1104837583","title":"Niagen Bioscience通過全現金交易向LGC出售Chromadex參考標準業務，精簡運營聚焦主業","url":"https://stock-news.laohu8.com/highlight/detail?id=1104837583","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104837583?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 20:10","pubTimestamp":1772107856,"startTime":"0","endTime":"0","summary":"Niagen Bioscience宣布将旗下Chromadex参考标准业务以全现金交易方式出售给LGC，旨在优化公司架构并集中资源发展核心业务。此次交易将帮助Niagen Bioscience进一步聚焦主营业务，提升运营效率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","NAGE","BK4121"],"gpt_icon":0},{"id":"2614038784","title":"BUZZ-Niagen Bioscience 股價因注射用 NAD+ 增效劑的美國專利而上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2614038784","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614038784?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 22:13","pubTimestamp":1772028829,"startTime":"0","endTime":"0","summary":"BUZZ-Niagen Bioscience 股价因注射用 NAD+ 增效剂的美国专利而上涨2月25日 - ** 制药商Niagen Bioscience NAGE.O股价盘前上涨3.3%至5.28美元** 该公司表示，它获得了一项新的美国专利，涵盖其NAD+促进成分Niagen的静脉注射和注射版本** Niagen是一种烟酰胺核苷，是一种维生素B3衍生物，用于提高NAD+水平，有助于支持细胞能量和修复，该公司称。** Niagen IV 已在超过 1,200 家诊所提供；公司称，新配方能更有效地提供 NAD+，且副作用更少。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nL4S3ZL1ED:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4183","NAGE"],"gpt_icon":0},{"id":"1114396120","title":"Niagen Bioscience公司獲得煙酰胺核苷靜脈注射與注射製劑及使用方法的新美國專利","url":"https://stock-news.laohu8.com/highlight/detail?id=1114396120","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114396120?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 21:37","pubTimestamp":1772026632,"startTime":"0","endTime":"0","summary":"Niagen Bioscience公司宣布，已成功获得一项新的美国专利，该专利涵盖了烟酰胺核苷的静脉注射制剂、注射制剂及其使用方法。这一专利的授予进一步巩固了该公司在相关技术领域的知识产权布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4121","NAGE"],"gpt_icon":0},{"id":"1198067768","title":"Niagen Bioscience收購自貝爾法斯特女王大學的核心煙酰胺核糖（Nr）專利組合","url":"https://stock-news.laohu8.com/highlight/detail?id=1198067768","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198067768?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 21:35","pubTimestamp":1766410508,"startTime":"0","endTime":"0","summary":"Niagen Bioscience收购自贝尔法斯特女王大学的核心烟酰胺核糖（Nr）专利组合","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","NAGE"],"gpt_icon":0},{"id":"1181839553","title":"Niagen Bioscience宣佈1000萬美元股票回購計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=1181839553","media":"投资观察","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181839553?lang=zh_tw&edition=fundamental","pubTime":"2025-11-20 00:59","pubTimestamp":1763571540,"startTime":"0","endTime":"0","summary":"11月6日 - Niagen Bioscience Inc宣布其将实施1000万美元的股票回购计划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","NAGE"],"gpt_icon":0},{"id":"1115306093","title":"Niagen Bioscience Inc：全年重申其最近修訂的淨銷售額增長指引為按年增長25%至30%","url":"https://stock-news.laohu8.com/highlight/detail?id=1115306093","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115306093?lang=zh_tw&edition=fundamental","pubTime":"2025-11-05 05:43","pubTimestamp":1762292589,"startTime":"0","endTime":"0","summary":"Niagen Bioscience Inc：全年重申其最近修订的净销售额增长指引为同比增长25%至30%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","NAGE"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}